David Schwartz

CIK 942587 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 2, 2004 · Latest: Feb. 2, 2004

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 84 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

84 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 7, 2004 BIO P 997 $10.45 $10,419 997 Direct Acquired 3375.9% (price as of 2026-08-19)
Jan. 7, 2004 BIO P 8,753 $9.50 $83,154 8,753 Direct Acquired 3723.5% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Dec. 14, 2011 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (54,850) $28.88 Feb. 6, 2012 54,850 Disposed
Nov. 4, 2011 BIO Restricted Stock Units Bio-Rad B Common Stock (1,500) 1,500 Acquired
Nov. 4, 2011 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (5,000) $100.06 Nov. 4, 2021 5,000 Acquired
Sept. 8, 2011 BIO Restricted Stock Units Bio-Rad B Common Stock (334) 334 Disposed
June 10, 2011 BIO Restricted Stock Units Bio-Rad B Common Stock (334) 334 Disposed
Sept. 8, 2010 BIO Restricted Stock Units Bio-Rad B Common Stock (1,670) 1,670 Acquired
Sept. 8, 2010 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (5,000) $84.57 Sept. 8, 2020 5,000 Acquired
Sept. 7, 2010 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (36,250) $11.94 Sept. 19, 2010 36,250 Disposed
Sept. 3, 2010 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (36,250) $11.94 Sept. 19, 2010 36,250 Disposed
June 10, 2010 BIO Restricted Stock Units Bio-Rad B Common Stock (334) 334 Disposed
June 10, 2009 BIO Restricted Stock Units Bio-Rad B Common Stock (1,670) 1,670 Acquired
June 10, 2009 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (5,000) $75.38 June 10, 2019 5,000 Acquired
Oct. 23, 2008 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (66,662) $11.31 Feb. 2, 2010 66,662 Disposed
June 11, 2008 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (5,000) $88.48 June 11, 2018 5,000 Acquired
Feb. 5, 2008 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (2,000) $39.60 Feb. 5, 2008 2,000 Disposed
Jan. 14, 2008 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (63,862) $11.97 Feb. 11, 2008 63,862 Disposed
Aug. 1, 2007 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (5,000) $75.00 Aug. 1, 2017 5,000 Acquired
Feb. 6, 2007 BIO Incentive Stock Option (right to boy) Bio-Rad B Common Stock (10,386) $31.77 Feb. 6, 2007 10,386 Disposed
Feb. 6, 2007 BIO Non-Qualified Stock Option 9right to buy) Bio-Rad B Common Stock (4) $28.88 Feb. 6, 2012 4 Disposed
Feb. 6, 2007 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (10,390) $31.77 Feb. 6, 2007 10,390 Disposed
Jan. 31, 2007 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (64,744) $15.82 Feb. 5, 2007 64,744 Disposed
April 3, 2006 BIO Incentive Stock Option (right to buy) Bio-Rad Common B (1,587) April 3, 2011 1,587 Acquired
April 3, 2006 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (1,587) $63.00 April 3, 2011 1,587 Acquired
April 3, 2006 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (8,413) $63.00 April 3, 2016 8,413 Acquired
Feb. 24, 2005 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (65,930) $12.96 Feb. 7, 2006 65,930 Disposed
Feb. 9, 2005 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (1,773) $62.04 Feb. 9, 2010 1,773 Acquired
Feb. 9, 2005 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (8,227) $56.40 Feb. 9, 2015 8,227 Acquired
Feb. 9, 2005 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (1,897) $62.04 Feb. 9, 2015 1,897 Acquired
Feb. 9, 2005 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (8,103) $56.40 Feb. 9, 2015 8,103 Acquired
Jan. 31, 2005 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (8,838) $12.44 Feb. 2, 2005 8,838 Disposed
Feb. 4, 2004 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (2,392) $58.85 Feb. 4, 2009 2,392 Acquired
Feb. 4, 2004 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (7,608) $53.50 Feb. 4, 2014 7,608 Acquired
Feb. 4, 2004 BIO Incentive Stock Option Class B common Stock (1,699) $58.85 Feb. 4, 2014 1,699 Acquired
Feb. 4, 2004 BIO Non Qualified Stock Option Class B Common Stock (8,301) $53.50 Feb. 4, 2014 8,301 Acquired
Jan. 7, 2004 BIO Non Qualified Stock Option Bio-Rad Class B Common Stock (8,753) $9.50 Feb. 3, 2004 8,753 Acquired
Jan. 7, 2004 BIO Incentive Stock Option Bio-Rad Laboratories Class B Common Stock (997) $10.45 Feb. 3, 2004 997 Acquired
Feb. 5, 2003 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (2,000) $39.60 Feb. 5, 2008 2,000 Acquired
Feb. 5, 2003 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (8,000) $36.00 Feb. 5, 2013 8,000 Acquired
Feb. 6, 2002 BIO Incentive Stock Option (right to buy) Bio-Rad B Common Stock (10,386) $31.77 Feb. 6, 2007 10,386 Acquired
Feb. 6, 2002 BIO Non-Qualified Stock Option (right to buy) Bio-Rad B Common Stock (54,854) $28.88 Feb. 6, 2012 54,854 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BIO

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2011 $520,000 $59,800 $19,920 $897,528
2010 $520,130 $208,000 $19,920 $1,035,425
2009 $540,065 $208,000 $20,215 $1,025,840

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.